CA Patent

CA2667453A1 — Triazolo-pyridazine protein kinase modulators

Assigned to SGX Pharmaceuticals Inc · Expires 2008-05-02 · 18y expired

What this patent protects

The present disclosure relates to triazolopyridazine protein kinase modulators of Formula (I), methods of using these compounds to treat diseases mediated by kinase activity.

USPTO Abstract

The present disclosure relates to triazolopyridazine protein kinase modulators of Formula (I), methods of using these compounds to treat diseases mediated by kinase activity.

Drugs covered by this patent

Patent Metadata

Patent number: CA2667453A1
Jurisdiction: CA
Classification: —
Expires: 2008-05-02
Drug substance claim: No
Drug product claim: No
Assignee: SGX Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.